Vascugen

Vascugen

Biotechnology, 5602 Research Park BLVD Ste 213, Madison, Wisconsin, 53719, United States, 11-50 Employees

vascugen.com

  • LinkedIn

phone no Phone Number: 16*********

Who is VASCUGEN

Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow, particularly for those patients at...

Read More

map
  • 5602 Research Park BLVD Ste 213, Madison, Wisconsin, 53719, United States Headquarters: 5602 Research Park BLVD Ste 213, Madison, Wisconsin, 53719, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VASCUGEN

Vascugen Org Chart and Mapping

Employees

Benjamin Wielgat

Biomanufacturing Specialist

Kemi Adeyanju

Project Manager Scientist & Intellectual Property Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vascugen

Answer: Vascugen's headquarters are located at 5602 Research Park BLVD Ste 213, Madison, Wisconsin, 53719, United States

Answer: Vascugen's phone number is 16*********

Answer: Vascugen's official website is https://vascugen.com

Answer: Vascugen's revenue is $1 Million to $5 Million

Answer: Vascugen's SIC: 2836

Answer: Vascugen's NAICS: 541714

Answer: Vascugen has 11-50 employees

Answer: Vascugen is in Biotechnology

Answer: Vascugen contact info: Phone number: 16********* Website: https://vascugen.com

Answer: Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow, particularly for those patients at high risk for amputation and death for whom few to no treatment options remain. The company’s lead product is an allogeneic vasculogenic cell – a cell with the potential to forge new blood vessels in oxygen-starved tissues. The vasculogenic cell product is manufactured from induced pluripotent stem cells (iPSCs), which provide a limitless source from which to produce off-the-shelf, cryopreserved doses at scale.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access